ASSOCIATION OF CISPLATIN (CDDP) AND 5-FLUOROURACIL (5-FU) IN THE TREATMENT OF SQUAMOUS-CELL CANCER OF THE METASTATIC LUNG (CSPM) - PHASE-II STUDY

被引：0
|
作者：
VENTURINI, M
NICOSIA, F
VENTURINI, S
TROIANI, R
LOMBARDI, M
SICARI, A
SPINELLI, I
机构：
[1] CIVICO OSPED,ONCOL,CARRARA,ITALY
[2] CIVICO OSPED,DIV CHIRURG,CARRARA,ITALY
来源：
TUMORI | 1986年 / 72卷 / 06期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：736 / 736
页数：1
相关论文
共 50 条
  • [1] Randomised phase II study of cisplatin and 5-fluorouracil (5-FU) versus cisplatin alone in advanced squamous cell oesophageal cancer
    Bleiberg, H
    Conroy, T
    Paillot, B
    Lacave, AJ
    Blijham, G
    Jacob, JH
    Bedenne, L
    Namer, M
    DeBesi, P
    Gay, F
    Collette, L
    Sahmoud, T
    [J]. EUROPEAN JOURNAL OF CANCER, 1997, 33 (08) : 1216 - 1220
  • [2] A PHASE-II STUDY OF CISPLATIN AND 5-FLUOROURACIL PLUS LEUCOVORIN FOR SQUAMOUS-CELL CARCINOMA OF THE ESOPHAGUS
    HAYASHI, K
    IDE, H
    SHINODA, M
    FUKUSHIMA, M
    [J]. CANCER RESEARCH THERAPY & CONTROL, 1993, 3 (02): : 115 - 119
  • [3] CHEMOTHERAPY WITH 5-FLUOROURACIL (5-FU) AND CISPLATIN OR 5-FU, CISPLATIN, AND VINBLASTINE FOR ADVANCED NON-SMALL-CELL LUNG-CANCER - A RANDOMIZED PHASE-II STUDY OF THE CANCER AND LEUKEMIA GROUP-B
    RICHARDS, F
    PERRY, DJ
    GOUTSOU, M
    MODEAS, C
    MUCHMORE, E
    REGE, V
    CHAHINIAN, AP
    HIRSH, V
    POIESZ, B
    GREEN, MR
    [J]. CANCER, 1991, 67 (12) : 2974 - 2979
  • [4] COMPARISON OF 5-FLUOROURACIL (5-FU) + CISPLATIN (CISDDPT) WITH 5-FU + CARBOPLATIN (CBDCA) AND 5-FU + IPROPLATIN (CHIP) IN SQUAMOUS-CELL LUNG CA LC-12
    TAPAZOGLOU, E
    CORBETT, T
    POLIN, L
    RATANATHARATHORN, V
    ALSARRAF, M
    [J]. PROCEEDINGS OF THE AMERICAN ASSOCIATION FOR CANCER RESEARCH, 1986, 27 : 373 - 373
  • [5] SALVAGE TREATMENT WITH CISPLATIN (CDDP) AND 5-FLUOROURACIL (5-FU) IN ADVANCED BREAST-CANCER PATIENTS
    PRONZATO, P
    AMOROSO, D
    BERTELLI, G
    LIONETTO, R
    ARDIZZONI, A
    CONTE, PF
    ROSSO, R
    GALLOTTI, P
    [J]. BREAST CANCER RESEARCH AND TREATMENT, 1987, 10 (01) : 108 - 108
  • [6] Phase II trial of cisplatin (CDDP), 5-Fluorouracil (5Fu) and folinic acid (FA) for relapsing or metastatic squamous cell cancer of the head and neck (SCCHN)
    Vaz, F
    Oliveira, J
    Ferreira, M
    Torrinha, F
    Fernandes, A
    [J]. ANNALS OF ONCOLOGY, 1998, 9 : 79 - 79
  • [7] Cisplatin (CDDP), 5-fluorouracil (5FU) and vinorelbine (NVB): A phase II study in advanced non small cell lung cancer (NSCLC)
    Livartowski, A
    Dierick, A
    Beuzeboc, P
    Paraiso, D
    Pouillart, P
    [J]. EUROPEAN JOURNAL OF CANCER, 1995, 31A : 1099 - 1099
  • [8] In-vitro effect of a combination of 5-fluorouracil (5-FU) and cisplatin (CDDP) on human gastric cancer cell lines: Timing of cisplatin treatment
    Cho H.
    Imada T.
    Oshima T.
    Shiozawa M.
    Rino Y.
    Takanashi Y.
    [J]. Gastric Cancer, 2002, 5 (1) : 43 - 46
  • [9] PHASE-II STUDY OF CISPLATIN AND CONTINUOUS-INFUSION 5-FLUOROURACIL AND BLEOMYCIN FOR RECURRENT AND METASTATIC HEAD AND NECK SQUAMOUS-CELL CARCINOMA
    TELLEZBERNAL, E
    BELEHRADEK, M
    RECONDO, G
    CVITKOVIC, E
    LERIDANT, AM
    VERICEL, R
    ARMAND, JP
    [J]. AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS, 1990, 13 (05): : 452 - 454
  • [10] Phase II study of 5-fluorouracil (5-Fu), cisplatin (CDDP) and vinorelbine (VNR) in patients (pts) with advanced adenocarcinoma of oesophagus.
    Vicent, JM
    García-Girón, C
    Feliu, J
    Berrocal, A
    Camps, C
    Barón, G
    Lara, MA
    [J]. EUROPEAN JOURNAL OF CANCER, 1999, 35 : S76 - S76
12345